AAV-Mediated Knock-In Cell Line Generation: Precise Genome Editing for Functional Genomics and Disease Modeling

Knock-in cell lines are engineered cell models in which a defined DNA sequence is precisely inserted into a specific genomic locus. Compared with knockout cell lines, which disrupt gene function, knock-in cell lines enable targeted gene modification while preserving genomic context. They can be used to introduce reporter tags, disease-associated mutations, epitope tags, selection markers, regulatory elements, or therapeutic sequences into a chosen genomic site.

With the development of CRISPR-Cas genome editing and adeno-associated virus, or AAV, donor delivery systems, knock-in cell line generation has become an important tool for functional genomics, cell signaling research, disease modeling, drug discovery, and gene therapy development. AAV is especially useful as a donor-template delivery platform because it can efficiently deliver homologous repair templates into many mammalian cells and has been widely used to support homology-directed repair, or HDR, for precise genome editing. CRISPR-Cas9-mediated HDR uses an exogenous donor template carrying the desired sequence to create precise insertions, deletions, or substitutions at a defined genomic site.

Why AAV-Mediated Knock-In Cell Lines Matter

Knock-in cell lines allow researchers to study genes in their native chromosomal environment. This is particularly valuable when expression level, promoter regulation, splicing, chromatin context, or protein localization is important. Instead of randomly overexpressing a gene from an episomal or integrated vector, knock-in strategies can introduce precise modifications at the endogenous locus.

AAV-mediated knock-in approaches are valuable for:

• Introducing fluorescent or epitope tags into endogenous genes.
• Creating disease-associated point mutations or correction models.
• Inserting reporter genes under endogenous regulatory control.
• Generating isogenic disease and control cell lines.
• Studying protein localization, stability, and interaction networks.
• Evaluating gene function in physiologically relevant expression contexts.
• Supporting cell therapy, immunology, cancer biology, and stem cell research.
• Delivering donor templates for precise genome editing in difficult-to-edit cells.

AAV6 has been widely used as a donor-template delivery platform in human cells, including T cells and hematopoietic stem and progenitor cells, for HDR-mediated targeted insertion. Published studies describe AAV donor templates as useful for inserting large gene cassettes and for supporting targeted integration in primary human cells.

General Workflow for AAV-Mediated Knock-In Cell Line Generation

AAV-mediated knock-in cell line generation begins with careful design of both the editing system and the donor template. A CRISPR nuclease, such as Cas9, is used to create a targeted double-strand break near the intended insertion site. The AAV donor template then provides the repair sequence, usually flanked by homology arms, so the cell can insert the desired sequence through HDR.

A typical workflow includes:

• Target site selection: Choose a genomic locus and insertion site that supports the intended modification without disrupting essential regulatory or coding elements unless disruption is part of the design.
• Guide RNA design: Select guide RNAs with high on-target activity and low predicted off-target risk, ideally close to the intended knock-in site.
• AAV donor template design: Build a donor cassette containing the desired insert, homology arms, and any necessary selection marker, reporter, or regulatory elements.
• Delivery of editing components: Introduce the CRISPR nuclease, guide RNA, and AAV donor template into target cells using appropriate delivery formats.
• Cell recovery and enrichment: Allow edited cells to recover, then enrich or select for cells carrying the intended knock-in when applicable.
• Clone isolation: Isolate single-cell clones using limiting dilution, fluorescence-activated cell sorting, or other clonal isolation approaches.
• Knock-in validation: Confirm correct insertion, allele status, expression, and function using molecular, protein-level, and functional assays.

Because HDR efficiency varies by cell type, cell-cycle state, donor design, insert size, and editing system, each knock-in project requires optimization.

Key Design Considerations

Successful knock-in generation depends on thoughtful donor and guide design. AAV has a limited packaging capacity, so the size of the donor template must be compatible with AAV delivery. Large inserts may require careful cassette design, shorter homology arms, removal of unnecessary elements, or alternative donor strategies. Split AAV donor systems have also been explored for larger gene cassettes.

Important design factors include:

• Insert size and AAV packaging capacity.
• Homology arm length and placement.
• Distance between the CRISPR cut site and insertion site.
• Whether the edit is N-terminal, C-terminal, intronic, or safe-harbor targeted.
• Selection marker or reporter design.
• Maintenance of endogenous gene regulation.
• Avoidance of unintended disruption to splice sites or regulatory elements.
• Inclusion of silent mutations when needed to prevent repeated Cas9 cutting.
• Compatibility with downstream validation assays.

For fluorescent tagging, it is important to confirm that the tag does not disrupt protein localization, function, or stability. For disease modeling, inserted mutations should be confirmed in the correct allele context and compared with matched control cells whenever possible.

Validation of Knock-In Cell Lines

Validation is one of the most important steps in knock-in cell line generation. Correct insertion should not be assumed based only on selection-marker expression or fluorescence. A well-validated knock-in cell line should be confirmed at the DNA, RNA, protein, and functional levels when appropriate.

Common validation methods include:

• Junction PCR to confirm correct 5′ and 3′ integration boundaries.
• PCR across the edited locus to distinguish wild-type, heterozygous, and homozygous alleles.
• Sanger sequencing or amplicon NGS to confirm precise insertion and sequence integrity.
• Copy number analysis to evaluate whether unintended additional integrations occurred.
• Southern blotting, long-read sequencing, or genome-wide methods for complex edits or high-confidence validation.
• RT-qPCR or RNA sequencing to assess transcript expression and splicing.
• Western blotting, flow cytometry, immunofluorescence, or microscopy to confirm protein expression and localization.
• Functional assays to confirm that the inserted sequence behaves as intended.

Published knock-in validation workflows have used combinations of junction PCR, Southern blotting, Sanger sequencing, microscopy, Western blotting, and live-cell imaging to confirm correctly tagged cell lines.

Applications of AAV-Mediated Knock-In Cell Lines

AAV-mediated knock-in cell lines support a broad range of biomedical research applications. In functional genomics, they help researchers study endogenous protein localization, dynamics, and interactions. In disease modeling, knock-in strategies can introduce patient-relevant mutations into otherwise matched cell lines, creating isogenic models that reduce genetic background variability.

In drug discovery, knock-in cell lines can support target validation, reporter assay development, biomarker studies, and mechanism-of-action research. In cell therapy research, AAV donor templates have been used in combination with CRISPR editing to insert therapeutic constructs into defined genomic loci, including targeted transgene insertion in T cells. For example, AAV donor templates have been used to support targeted CAR insertion into the TRAC locus in T cells, placing the transgene under endogenous regulatory control.

Common applications include:

• Endogenous fluorescent protein tagging.
• Epitope tagging for protein detection and pulldown studies.
• Safe-harbor transgene insertion.
• Disease mutation modeling.
• Reporter cell line development.
• Target validation and drug screening.
• Cell therapy engineering research.
• Gene correction and repair-template optimization studies.

Challenges and Technical Considerations

Although AAV-mediated knock-in is powerful, it presents several challenges. HDR is often less efficient than non-homologous end joining, and efficiency can be low in non-dividing or difficult-to-edit cells. The AAV donor must fit within packaging constraints, and high levels of donor template or nuclease activity may increase unwanted events. Precise insertion must also be distinguished from random integration, partial integration, concatemer formation, or on-target indels without donor insertion.

Key challenges include:

• Variable HDR efficiency across cell types.
• AAV packaging limits for large donor templates.
• Potential random or partial donor integration.
• Monoallelic versus biallelic knock-in outcomes.
• Off-target editing by CRISPR nucleases.
• Clonal variability after single-cell isolation.
• Need for multiple validation layers.
• Possible disruption of endogenous gene expression or protein function.

To improve reliability, researchers should validate multiple independent clones, include matched controls, and use orthogonal assays to confirm correct insertion and functional performance.

Conclusion

AAV-mediated knock-in cell line generation is a powerful strategy for precise genome engineering. By combining CRISPR-Cas editing with AAV donor-template delivery, researchers can introduce defined genetic modifications into specific genomic loci and create more physiologically relevant cell models.

Successful knock-in cell line development requires careful target selection, guide RNA design, AAV donor template construction, clonal screening, and multi-layer validation. When properly designed and confirmed, AAV-supported knock-in cell lines can provide valuable tools for studying gene function, disease mechanisms, protein dynamics, drug response, and gene therapy development.